These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 6600158)

  • 1. Relationship between mezerein-mediated biological responses and phorbol ester receptor occupancy.
    Jaken S; Shupnik MA; Blumberg PM; Tashjian AH
    Cancer Res; 1983 Jan; 43(1):11-4. PubMed ID: 6600158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
    Jeng AY; Lichti U; Strickland JE; Blumberg PM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells.
    Jaken S; Tashjian AH; Blumberg PM
    Cancer Res; 1981 Dec; 41(12 Pt 1):4956-60. PubMed ID: 6272986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of phorbol ester receptors and their down-modulation in GH4C1 rat pituitary cells.
    Jaken S; Tashjian AH; Blumberg PM
    Cancer Res; 1981 Jun; 41(6):2175-81. PubMed ID: 6786733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells.
    Blumberg PM; Delclos KB; Dunphy WG; Jaken S
    Carcinog Compr Surv; 1982; 7():519-35. PubMed ID: 7039833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of specific binding sites for phorbol ester tumor promoters in human epidermal and dermal cells in culture but lack of down regulation in epidermal cells.
    Chida K; Kuroki T
    Cancer Res; 1983 Aug; 43(8):3638-42. PubMed ID: 6574816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
    Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB
    J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester binding to chemotactically responding and nonresponding Walker 256 carcinosarcoma cells.
    Clarke PR; Varani J
    Cancer Res; 1984 Nov; 44(11):4967-71. PubMed ID: 6593115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.
    Horowitz AD; Fujiki H; Weinstein IB; Jeffrey A; Okin E; Moore RE; Sugimura T
    Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of phorbol esters to high-affinity sites on murine fibroblastic cells elicits a mitogenic response.
    Collins MK; Rozengurt E
    J Cell Physiol; 1982 Jul; 112(1):42-50. PubMed ID: 6286693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the growth inhibition induced by tumor-promoting phorbol esters and of their receptor binding in A549 human lung carcinoma cells.
    Gescher A; Reed DJ
    Cancer Res; 1985 Sep; 45(9):4315-21. PubMed ID: 3861245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of phorbol ester receptor down modulation in human myeloblastic leukemia ML-1 cells by differentiation-stimulating serum components.
    Sakagami H; Hromchak R; Block A
    Cancer Res; 1984 Aug; 44(8):3330-5. PubMed ID: 6331642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second stage tumor promoters: differences in biological potency and phorbol ester receptor affinity in C6 cells.
    Leach KL; Frost MM; Blumberg PM; Bressler JP
    Cancer Lett; 1987 Aug; 36(2):139-47. PubMed ID: 3040225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters.
    Weinberg JB; Misukonis MA; Goodwin BJ
    Cancer Res; 1984 Mar; 44(3):976-80. PubMed ID: 6318990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of tumor promotion and multistage carcinogenesis.
    Weinstein IB; Arcoleo J; Backer J; Jeffrey A; Hsiao WL; Gattoni-Celli S; Kirschmeier P; Okin E
    Princess Takamatsu Symp; 1983; 14():59-74. PubMed ID: 6097583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly lipophilic phorbol esters as inhibitors of specific [3H]phorbol 12,13-dibutyrate binding.
    Sharkey NA; Blumberg PM
    Cancer Res; 1985 Jan; 45(1):19-24. PubMed ID: 3855281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptors interact with transforming growth factors produced by certain human tumor cells and are distinct from specific membrane receptors for phorbol and ingenol esters.
    Todaro GJ; De Larco JE; Shoyab M
    Carcinog Compr Surv; 1982; 7():443-62. PubMed ID: 6279294
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific binding of [20-3H]12-deoxyphorbol 13-isobutyrate to phorbol ester receptor subclasses in mouse skin particulate preparations.
    Dunn JA; Blumberg PM
    Cancer Res; 1983 Oct; 43(10):4632-7. PubMed ID: 6309373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of epidermal growth factor binding to mouse embryonal carcinoma cells by phorbol esters mediated by specific phorbol ester receptors.
    Salomon DS
    J Biol Chem; 1981 Aug; 256(15):7958-66. PubMed ID: 6267031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.